Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C

BACKGROUND/AIMS: Peginterferon plus ribavirin remains a standard therapy for patients with chronic hepatitis C (CHC) in Korea. We investigated the efficacy and long-term outcome of peginterferon and ribavirin therapy in Korean patients with CHC, particularly in relation to the stage of liver fibrosi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Gut Liver
Auteurs principaux: Jung, Chang Ho, Um, Soon Ho, Kim, Tae Hyung, Yim, Sun Young, Suh, Sang Jun, Yim, Hyung Joon, Seo, Yeon Seok, Choi, Hyuk Soon, Chun, Hoon Jai
Format: Artigo
Langue:Inglês
Publié: Editorial Office of Gut and Liver 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5003206/
https://ncbi.nlm.nih.gov/pubmed/27114417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl15360
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires